These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6263523)

  • 1. The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro.
    Ryall RL; Harnett RM; Marshall VR
    Clin Chim Acta; 1981 May; 112(3):349-56. PubMed ID: 6263523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnesium, citrate, magnesium citrate and magnesium-alkali citrate as modulators of calcium oxalate crystallization in urine: observations in patients with recurrent idiopathic calcium urolithiasis.
    Schwille PO; Schmiedl A; Herrmann U; Fan J; Gottlieb D; Manoharan M; Wipplinger J
    Urol Res; 1999 Apr; 27(2):117-26. PubMed ID: 10424393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of pyrophosphate, citrate, magnesium and chondroitin sulphate in calcium oxalate urolithiasis.
    Grases F; Genestar C; Conte A; March P; Costa-Bauzá A
    Br J Urol; 1989 Sep; 64(3):235-7. PubMed ID: 2553195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of citrate and urine on calcium oxalate crystal aggregation.
    Tiselius HG; Fornander AM; Nilsson MA
    Urol Res; 1993; 21(5):363-6. PubMed ID: 8279094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between urinary inhibitory activity and endogenous concentrations of glycosaminoglycans and uric acid: comparison of urines from stone-formers and normal subjects.
    Ryall RL; Marshall VR
    Clin Chim Acta; 1984 Aug; 141(2-3):197-204. PubMed ID: 6488555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Introduction of an enzyme method for determining pyrophosphate in urine--a comparative study between patients with calculi and normal probands].
    Genester C; Salgado J; Coll R; Conte A; Grases F
    Z Urol Nephrol; 1989 Jul; 82(7):369-73. PubMed ID: 2549749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifiers of calcium oxalate crystallization found in urine. I. Studies with a continuous crystallizer using an artificial urine.
    Robertson WG; Scurr DS
    J Urol; 1986 Jun; 135(6):1322-6. PubMed ID: 2423714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macromolecular inhibitors of calcium oxalate crystal growth and aggregation.
    Brockis JG; Bowyer RC; McCulloch RK
    Scand J Urol Nephrol Suppl; 1980; 53():67-74. PubMed ID: 6938008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Juvenile renal stone disease: a study of urinary promoting and inhibiting factors.
    Baggio B; Gambaro G; Favaro S; Borsatti A; Pavanello L; Siviero B; Zacchello G; Rizzoni GF
    J Urol; 1983 Dec; 130(6):1133-5. PubMed ID: 6315967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of calcium oxalate monohydrate crystallization kinetics in vitro.
    Kok DJ; Papapoulos SE; Blomen LJ; Bijvoet OL
    Kidney Int; 1988 Sep; 34(3):346-50. PubMed ID: 2459439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of monosodium urate on the capacity of urine, chondroitin sulphate and heparin to inhibit calcium oxalate crystal growth and aggregation.
    Ryall RL; Harnett RM; Marshall VR
    J Urol; 1986 Jan; 135(1):174-7. PubMed ID: 3079836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for urinary calcium oxalate crystals as revealed by their specific enzymatic assay.
    Hallson PC; Rose GA
    Br J Urol; 1989 Nov; 64(5):451-7. PubMed ID: 2611612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion of citrate, glycosaminoglycans, magnesium and zinc in relation to age and sex in normal subjects and in patients who form calcium stones.
    Trinchieri A; Mandressi A; Luongo P; Rovera F; Longo G
    Scand J Urol Nephrol; 1992; 26(4):379-86. PubMed ID: 1292077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [High molecular weight substances which inhibit calcium oxalate crystal growth. 1: Relative potencies of various kinds of urinary inhibitors which were determined new assay method (author's transl)].
    Ito H; Shimazaki J
    Nihon Hinyokika Gakkai Zasshi; 1978 Oct; 69(10):1334-41. PubMed ID: 215812
    [No Abstract]   [Full Text] [Related]  

  • 15. Urinary inhibitor of the formation of calcium oxalate.
    Sutor DJ; Percival JM; Doonan S
    Br J Urol; 1979 Aug; 51(4):253-5. PubMed ID: 223711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystallization properties in urine from calcium oxalate stone formers.
    Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
    J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of crystal growth of hydroxyapatite: a constant composition approach.
    Wilson JW; Werness PG; Smith LH
    J Urol; 1985 Dec; 134(6):1255-8. PubMed ID: 2997488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine.
    Suzuki K; Mayne K; Doyle IR; Ryall RL
    Scanning Microsc; 1994; 8(3):523-30. PubMed ID: 7747154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Estimation of 24-h excretion of some promotors and inhibitors of crystallization and degree of urine saturation with calcium oxalate in calcium urinary calculi].
    Boruczkowska A
    Pol Arch Med Wewn; 1994 Oct; 92(4):289-98. PubMed ID: 7854956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyanionic inhibitors of calcium oxalate crystal agglomeration in urine.
    Scurr DS; Latif AB; Sergeant V; Robertson WG
    Proc Eur Dial Transplant Assoc; 1983; 20():440-4. PubMed ID: 6197713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.